Infants with alpha-thalassaemia major (haemoglobin Bart's hydrops foetalis) who survive the neonatal period become lifelong transfusion-dependent unless cured by haematopoietic stem cell transplantation. This protocol addresses the management step that follows when regular transfusion has not achieved the required haemoglobin target.
Alpha thalassemia minor in a patient with alpha-thalassaemia major (haemoglobin Bart's hydrops foetalis) — a severe form requiring ongoing haematological intervention from early infancy.
Regular blood transfusion was the first-line approach, aiming to maintain functional haemoglobin (non-HbH haemoglobin) above 90 g/L. Escalation to this protocol is indicated when functional haemoglobin has not been maintained above that threshold.
The protocol centres on initiation of iron chelation therapy, started in early infancy with careful monitoring for toxicity. The specific choice of chelating agent, the schedule, and any combined approach are set out in the full structured protocol.